Israeli researchers find cannabis compounds could lead to 1st drug for fatty liver disease

Two compounds from a cannabis plant could help what’s commonly known as “fatty liver disease,” Israeli researchers say.

Metabolic dysfunction-associated steatotic liver disease, known as MASLD, is the most common liver problem in the…

Continue Reading


News Source: www.timesofisrael.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *